Omini Company
Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers. It provides personalized blood biomarker data that can be used to adjust therapies and prevent acute crises in patients with chronic conditions.
Total Funding:
2055002
Founded Date:
2019-01-01
Industry:
Magnetometry
Last Funding Date:
2024-07-15
Funding Status:
private
Headquarters:
Paris,Ile-de-France,France,Europe
Super Industry:
Quantum Sensing
Funding Stage:
Seed
Funding Total Value:
1700000
Founders:
Anna Shirinskaya,Joanne Kanaan